Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Trump Administration Drops Tariffs On Certain Medtech Imports From China

Executive Summary

The Trump administration has decided to waive tariffs on certain medtech products imported from China that could help the US combat the ongoing COVID-19 crisis.

You may also be interested in...



COVID-19: AdvaMed Asks USTR To Drop Tariffs On More Chinese Medtech Products

The largest medtech industry group has asked the Office of the US Trade Representative to waive tariffs on more medical devices imported from China as the US fights the COVID-19 crisis. AdvaMed wants an indefinite waiver, or at least one that extends a year beyond when the WHO declares an end to the pandemic.

Former FDA Chief Urges Manufacturers To Shift Gears In Coronavirus Efforts

In a series of tweets on 16 March, former US FDA commissioner Robert Califf urged manufacturers – regardless of industry – to consider shifting their production to aid in making personal protective equipment such as gloves, masks and gowns.

COVID-19: FDA Expands Overseas Inspections Freeze Through April

Industry experts advise companies to prepare for paper-based inspection in light of the US FDA's suspended overseas inspections in response to the COVID-19 crisis.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT126377

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel